P N Hawkins|M B Pepys - JoVE Visualize

Showing results (21-30 of 284) with videos related to

Pageof 29

Sort By:

QJM : Monthly Journal of the Association of Physicians|February 20, 1999

Pyrin/marenostrin mutations in familial Mediterranean feverD R Booth, J D Gillmore, S E Booth, et al.

Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 26, 1999

SAA1 alleles as risk factors in reactive systemic AA amyloidosisD R Booth, S E Booth, J D Gillmore, et al.

QJM : Monthly Journal of the Association of Physicians|April 9, 2002

Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable diseaseH J Lachmann, J A Gilbertson, J D Gillmore, et al.

European Journal of Nuclear Medicine|July 15, 1998

Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantationA Rydh, O Suhr, S O Hietala, et al.

Transplantation|June 30, 1998

Domino hepatic transplantation using the liver from a patient with familial amyloid polyneuropathyA J Stangou, N D Heaton, M Rela, et al.

The American Journal of Cardiology|November 14, 1997

Echocardiographic assessment of cardiac involvement in systemic AL amyloidosis in relation to whole body amyloid load measured by serum amyloid P component (SAP) clearanceG J Clesham, D M Vigushin, P N Hawkins, et al.

Biochemical and Biophysical Research Communications|June 15, 1994

Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer's diseaseP N Hawkins, M N Rossor, J R Gallimore, et al.

European Journal of Nuclear Medicine|July 15, 1998

Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosisP N Hawkins, C Aprile, G Capri, et al.

Lancet (London, England)|March 21, 1981

C-reactive protein fifty years onM B Pepys

The Quarterly Journal of Medicine|June 1, 1993

Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regressionP N Hawkins, S Richardson, J E MacSweeney, et al.

Pageof 29

Showing results (21-30 of 284) with videos related to

Sort By:

Pageof 29

QJM : Monthly Journal of the Association of Physicians|February 20, 1999

Pyrin/marenostrin mutations in familial Mediterranean feverD R Booth, J D Gillmore, S E Booth, et al.

Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 26, 1999

SAA1 alleles as risk factors in reactive systemic AA amyloidosisD R Booth, S E Booth, J D Gillmore, et al.

QJM : Monthly Journal of the Association of Physicians|April 9, 2002

Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable diseaseH J Lachmann, J A Gilbertson, J D Gillmore, et al.

European Journal of Nuclear Medicine|July 15, 1998

Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantationA Rydh, O Suhr, S O Hietala, et al.

Transplantation|June 30, 1998

Domino hepatic transplantation using the liver from a patient with familial amyloid polyneuropathyA J Stangou, N D Heaton, M Rela, et al.

The American Journal of Cardiology|November 14, 1997

Biochemical and Biophysical Research Communications|June 15, 1994

Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer's diseaseP N Hawkins, M N Rossor, J R Gallimore, et al.

European Journal of Nuclear Medicine|July 15, 1998

Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosisP N Hawkins, C Aprile, G Capri, et al.